Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues
K. J. Schmidt(University Hospital Schleswig-Holstein), Jürgen Büning(University Hospital Schleswig-Holstein), Daniel C. Baumgart(University of Alberta), K Herrlinger(Robert Bosch Hospital), Hendrik Lehnert(University of Salzburg), Niklas F. Müller(University Hospital Schleswig-Holstein), Axel Dignaß(Goethe University Frankfurt), EF Stange(Robert Bosch Hospital), Klaus Fellermann(Apple (Israel))
Cited by 23
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Crohn's disease
|The Lancet|2012|2.1k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969